About this course

  • Released: 04/23/2012
  • Expires: 04/24/2014

Learning Objectives:

Upon completion of the article by Silberstein et al, the participant should be able to:
• Summarize the findings from this evidence-based guideline update regarding the studies of the pharmacologic treatment for episodic migraine prevention in adults
• Discuss the recommendations of this guideline update and their levels of evidence
• Recognize the need for further sound randomized controlled trials of episodic migraine prevention

Core Competencies:

The article by Silberstein et al covers the following core competency:
• Medical Knowledge


Learning Objectives:

Upon completion of the article by Holland et al, the participant should be able to:
• Summarize the findings from this evidence-based guideline update regarding the studies of anti-inflammatory or complementary treatments for episodic migraine prevention in adults
• Discuss the recommendations of this guideline update and their levels of evidence regarding the use of anti-inflammatory or complementary treatments in migraine prevention
• Discuss the recommendations for future research regarding these therapies as discussed in this guideline update

Core Competencies:

The article by Holland et al covers the following core competency:
• Medical Knowledge


Author Disclosures
Refer to listing above the references in each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

Content failed to load, please try again later.

ACCME